Stem Cells Translational Medicine最新文献

筛选
英文 中文
JAG1 c.1615C > T mutation impairs bile duct regeneration but not differentiation in hepatic organoids derived from a patient with Alagille syndrome. JAG1 c.1615C > T突变会损害胆管再生,但不会损害Alagille综合征患者肝类器官的分化
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-09-18 DOI: 10.1093/stcltm/szag073
Zirui Wan, Haiyan Zhang, Lu Zhang, Xiaofang Cao, Lisha An, Bin Wang, Jingyun Guan, Jinlin Jia, Chen Liu, Xiaohua Jin, Yue Li, Guohua Liu, Xu Ma
{"title":"JAG1 c.1615C > T mutation impairs bile duct regeneration but not differentiation in hepatic organoids derived from a patient with Alagille syndrome.","authors":"Zirui Wan, Haiyan Zhang, Lu Zhang, Xiaofang Cao, Lisha An, Bin Wang, Jingyun Guan, Jinlin Jia, Chen Liu, Xiaohua Jin, Yue Li, Guohua Liu, Xu Ma","doi":"10.1093/stcltm/szag073","DOIUrl":"10.1093/stcltm/szag073","url":null,"abstract":"<p><strong>Objective: </strong>Alagille syndrome (ALGS) is an autosomal dominant disorder caused primarily by mutations in JAG1. Intrahepatic bile duct paucity is the most consistently reported feature of ALGS; however, the mechanisms associated with biliary defects remain unclear.</p><p><strong>Methods: </strong>Here, we reverted or introduced the JAG1 c.1615C > T mutation to patient-specific induced pluripotent stem cells (iPSC) or human embryonic stem cells (hESCs) using base editors to generate isogenic cell lines and examine cellular phenotypes associated with this mutation in hepatic organoids.</p><p><strong>Results: </strong>We observed that JAG1 mutant lines showed no significant differences in cholangiocyte differentiation or function compared with the corresponding wild-type lines. By contrast, organoids derived from JAG1 mutant cells showed reduced cell survival, attenuated responsiveness to VEGF stimulation, and abnormal cell polarity.</p><p><strong>Conclusions: </strong>These findings offer a new insight into the biliary pathologies in ALGS and provide theoretical support for future proof-of-concept studies of novel therapeutic approaches for ALGS.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 10","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13593616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149017375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study. 40-65岁严重再生障碍性贫血患者单倍体造血干细胞移植与免疫抑制治疗:一项回顾性比较研究
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-09-18 DOI: 10.1093/stcltm/szag076
Sheng-Nan Gao, Jin-Song Jia, Xiao-Jun Huang, Yuan-Yuan Zhang, Ting-Ting Han, Hai-Xia Fu, Yun He, Yao Chen, Jing-Zhi Wang, Xiao-Dong Mo, Yu-Qian Sun, Wei Han, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Zheng-Li Xu
{"title":"Haploidentical HSCT vs immunosuppressive therapy for severe aplastic anemia in patients aged 40-65 years: a retrospective comparative study.","authors":"Sheng-Nan Gao, Jin-Song Jia, Xiao-Jun Huang, Yuan-Yuan Zhang, Ting-Ting Han, Hai-Xia Fu, Yun He, Yao Chen, Jing-Zhi Wang, Xiao-Dong Mo, Yu-Qian Sun, Wei Han, Yu Wang, Xiao-Hui Zhang, Lan-Ping Xu, Zheng-Li Xu","doi":"10.1093/stcltm/szag076","DOIUrl":"https://doi.org/10.1093/stcltm/szag076","url":null,"abstract":"<p><p>Severe aplastic anemia (SAA) is a life-threatening hematological disorder, and the optimal treatment for patients aged ≥40 years remains controversial. This retrospective study aims to conduct a comparative analysis of the efficacy of immunosuppressive therapy (IST) versus haploidentical hematopoietic stem cell transplantation (haplo-HSCT) specifically in elderly patients. To minimize selection bias, propensity score matching (PSM) was performed to pair samples based on age and Eastern Cooperative Oncology Group score, thereby addressing treatment responses and survival outcomes while ensuring balanced baseline characteristics between the 2 groups. The study reveals that while overall survival (OS) rates were similar (69.6% ± 13.3% vs. 68.6% ± 12.1%, P = 0.80), haplo-HSCT significantly outperformed IST in terms of failure-free survival (FFS) rates (68.7% ± 12.1% vs. 46.5% ± 20.2%, P = 0.025). Multivariate Cox regression analysis confirmed that treatment modality and disease severity were independent predictors of FFS. These findings support haplo-HSCT as a viable first-line treatment option for appropriately selected elderly SAA patients, providing evidence for treatment options in patients with SAA aged 40 and above.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 10","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13629439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149115005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fate of long-term culture on hepatocyte-like cells generated from human adipose-derived mesenchymal stem cells. 人脂肪源性间充质干细胞产生的肝细胞样细胞长期培养的结果。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-09-18 DOI: 10.1093/stcltm/szag061
Mengling Ji, Yu Saito, Yuhei Waki, Shuhai Chen, Tetsuya Ikemoto, Takayuki Noma, Hiroki Teraoku, Shinichiro Yamada, Yuji Morine, Mitsuo Shimada
{"title":"Fate of long-term culture on hepatocyte-like cells generated from human adipose-derived mesenchymal stem cells.","authors":"Mengling Ji, Yu Saito, Yuhei Waki, Shuhai Chen, Tetsuya Ikemoto, Takayuki Noma, Hiroki Teraoku, Shinichiro Yamada, Yuji Morine, Mitsuo Shimada","doi":"10.1093/stcltm/szag061","DOIUrl":"10.1093/stcltm/szag061","url":null,"abstract":"<p><strong>Background: </strong>We previously established a 21-day protocol to generate hepatocyte-like cells (HLCs) from adipose-derived stem cells and are conducting preclinical studies toward their clinical application in liver failure. This study examined how long HLCs maintain viability and hepatocyte-specific functions after differentiation.</p><p><strong>Methods: </strong>Adipose-derived stem cells (2.0 × 106) were differentiated into HLCs using a 3-step protocol for 21 days. After differentiation, cells were either transferred to transplantation medium (TM), used clinically, or maintained in step-3 differentiation medium (DM). Cell viability, hepatocyte-specific gene expression, and functional assays were performed on days 24 and 28. Because bile acid synthesis may induce cytotoxicity during extended culture, the expression of bile acid-related genes and transporters was evaluated on day 35.</p><p><strong>Results: </strong>Viability markedly decreased when HLCs were transferred to TM, whereas cells maintained in DM preserved viability up to day 28. The expression of mature hepatocyte markers (AAT, ALB, CPS1, and OTC) remained comparable between days 21 and 28. Hepatocyte functions, including CYP3A4 activity and ammonia metabolism, were also sustained in DM-cultured HLCs. Importantly, genes involved in bile acid synthesis and transport, which could contribute to cytotoxicity during prolonged culture, were undetectable even after 28 days.</p><p><strong>Conclusion: </strong>HLCs generated using our protocol maintained viability and hepatocyte-specific functions for at least 28 days when cultured in DM, without detectable bile acid-related gene expression. These findings suggest that transplantation timing can be flexibly adjusted for at least 1 week after the completion of differentiation.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 10","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13588577/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149002520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of intrathecal injection of mesenchymal stem cell-neural progenitors on cerebrospinal fluid biomarkers in progressive multiple sclerosis. 鞘内注射间充质干细胞-神经祖细胞对进行性多发性硬化患者脑脊液生物标志物的影响。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-09-18 DOI: 10.1093/stcltm/szag083
Violaine K Harris, Andrea Jiang, Sofia Ricciarini, Nikki Jagid, Maureen McCormick, Cara Kizilbash, Saud A Sadiq
{"title":"Effect of intrathecal injection of mesenchymal stem cell-neural progenitors on cerebrospinal fluid biomarkers in progressive multiple sclerosis.","authors":"Violaine K Harris, Andrea Jiang, Sofia Ricciarini, Nikki Jagid, Maureen McCormick, Cara Kizilbash, Saud A Sadiq","doi":"10.1093/stcltm/szag083","DOIUrl":"10.1093/stcltm/szag083","url":null,"abstract":"<p><p>Mesenchymal stem cell-neural progenitors (MSC-NP) are a bone marrow mesenchymal stem cell-derived population of cells with trophic and immunomodulatory properties with therapeutic potential in multiple sclerosis (MS). Early phase clinical trials have investigated the safety and efficacy of intrathecal administration of autologous MSC-NPs in people with progressive MS. To better understand the biological response to MSC-NP treatment, we analyzed cerebrospinal fluid (CSF) biomarkers in 2 separate cohorts of trial subjects with secondary progressive or primary progressive MS from both a phase 2 trial (n = 50) and an expanded access trial (n = 43) who received repeated administrations of autologous MSC-NPs. Candidate biomarkers identified through proteomic screening were validated in both cohorts, revealing a panel of 4 biomarkers (CCL2, C-C motif chemokine ligand-2; MMP9, matrix metalloproteinase-9; SCF, stem cell factor/c-kit ligand; and CHIT1, chitotriosidase-1) that were significantly changed in CSF but not serum following treatment. Other MS biomarkers neurofilament light and glial fibrillary acidic protein were unchanged following treatment but correlated with age, and both age and Expanded Disability Status Scale (EDSS), respectively. The specific biomarker changes observed following MSC-NP injections suggest distinct biological effects following MSC-NP treatment. These biomarkers help define the pharmacodynamic response to MSC-NP treatment as well as guide the design of future clinical studies.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 10","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13585449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148991522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Up to 19-year cryopreservation does not impair hematopoietic progenitor function in cord blood: a 1129-unit analysis from the largest Korean public cord blood bank. 长达19年的低温保存不会损害脐带血中的造血祖细胞功能:一项来自韩国最大的公共脐带血银行的1129个单位的分析。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag075
Eun Youn Roh, Hye Ryun Lee, Sue Shin, Jong Hyun Yoon, Nam-Hee Kim, Hyun-Woong Park, Byoung Jae Kim
{"title":"Up to 19-year cryopreservation does not impair hematopoietic progenitor function in cord blood: a 1129-unit analysis from the largest Korean public cord blood bank.","authors":"Eun Youn Roh, Hye Ryun Lee, Sue Shin, Jong Hyun Yoon, Nam-Hee Kim, Hyun-Woong Park, Byoung Jae Kim","doi":"10.1093/stcltm/szag075","DOIUrl":"10.1093/stcltm/szag075","url":null,"abstract":"<p><strong>Background: </strong>Whether umbilical cord blood (UCB) quality is maintained during decades of cryopreservation is critical for public banking policy. We analyzed post-thaw quality of 1129 UCB units cryopreserved for up to 19 years at Korea's largest public cord blood bank and examined implications for shelf-life policy.</p><p><strong>Methods: </strong>UCB units manually volume-reduced and cryopreserved between 2006 and 2025 underwent pre-transplant testing using their attached integral segments (median storage 6.5 years; range 16 days-19.0 years). Associations between storage duration and 19 quality indicators and 13 paired pre-/post-thaw complete blood count parameters were analyzed by Spearman correlation (ρ) before and after adjusting for era effects (processing and testing dates) to separate genuine storage effects from longitudinal analytical variation. Predictors of colony-forming unit (CFU) were ranked by univariate correlation and a Random Forest machine-learning model. Compliance with German/FACT-NetCord pre-transplant criteria was assessed.</p><p><strong>Results: </strong>Associations between storage duration and quality indicators were modest before adjustment (|ρ| ≤ 0.4) and were largely abolished once differences in testing era were taken into account: the storage-duration correlations for viable CD45+ and viable CD34+ both lost significance, as did CFU/CD34 + (P = .327). The post-thaw CD34+ count was the strongest predictor of CFU. Testing date, although ranked only seventh by simple correlation, rose to second in the Random Forest model, indicating an era effect not captured by pairwise analysis. The composite pre-transplant criteria pass rate was 96.2%, remaining above 93% across all storage bins.</p><p><strong>Conclusions: </strong>After up to 19 years of cryopreservation, per-CD34+ colony-forming capacity is preserved. A test-based shelf-life policy is more evidence-based than a predetermined expiration limit.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13505624/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148819435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intranasal stem cell treatment ameliorates neuroinflammation and myelin aberrations in fetal growth-restricted rat pups. 鼻内干细胞治疗可改善胎儿生长受限大鼠幼崽的神经炎症和髓磷脂畸变。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag081
Judit Alhama-Riba, Anastasija Aleksić, Nicola Pelizzi, Freek E Hoebeek, Caroline G M de Theije, Cora H A Nijboer
{"title":"Intranasal stem cell treatment ameliorates neuroinflammation and myelin aberrations in fetal growth-restricted rat pups.","authors":"Judit Alhama-Riba, Anastasija Aleksić, Nicola Pelizzi, Freek E Hoebeek, Caroline G M de Theije, Cora H A Nijboer","doi":"10.1093/stcltm/szag081","DOIUrl":"10.1093/stcltm/szag081","url":null,"abstract":"<p><p>Fetal growth restriction (FGR), a condition in which a fetus fails to reach its full growth potential, affects approximately 30 million infants worldwide each year and increases the risk of long-term neurodevelopmental deficits. Currently, no effective therapies exist to mitigate FGR-induced neurological impairments. Mesenchymal stem cells (MSCs) have emerged as a promising neuroregenerative therapeutic approach. Here, we used the reduced uterine perfusion pressure (RUPP) rat model of chronic placental hypoperfusion-induced FGR. We explored, for the first time, intranasal MSC administration in the early postnatal period in growth-restricted offspring as a minimally invasive and clinically feasible cell delivery approach. RUPP pups received human Wharton's jelly-derived MSCs or vehicle intranasally at postnatal day 5 (P5) or P10, and neuropathological outcomes were assessed at P20. Pups from sham-operated dams served as controls. Intranasal MSC treatment, particularly at the early postnatal treatment timepoint (P5), ameliorated key neuropathological outcomes, as evidenced by improved brain weight and cortical myelination, enhanced oligodendrocyte maturation, and dampened microglial activation compared to vehicle-treated RUPP pups. Functional impairments, measured between P13 and P56 by eye opening, grip strength, and foot faults on the tapered beam walk, showed no significant improvement. Our findings provide proof-of-concept that early-life stem cell therapy provides histological improvements in RUPP-induced brain abnormalities. Although further optimization is needed to establish whether these effects translate into functional benefits, intranasal MSCs represent a promising, minimally invasive neuroregenerative strategy with potential clinical relevance for newborns affected by chronic placental insufficiency-induced FGR.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13570797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148956588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exosome therapy for knee osteoarthritis: a network meta-analysis based on rat models. 膝关节骨关节炎的外泌体治疗:基于大鼠模型的网络荟萃分析。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag069
Yixiang Zhao, Haochuan You, Xiuyuan Wang, Xiping Dou, Jiangying Zhang, Yuzhe He, Lei Chen, Fei Huang, Yayi Xia
{"title":"Exosome therapy for knee osteoarthritis: a network meta-analysis based on rat models.","authors":"Yixiang Zhao, Haochuan You, Xiuyuan Wang, Xiping Dou, Jiangying Zhang, Yuzhe He, Lei Chen, Fei Huang, Yayi Xia","doi":"10.1093/stcltm/szag069","DOIUrl":"https://doi.org/10.1093/stcltm/szag069","url":null,"abstract":"<p><strong>Objective: </strong>To compare the therapeutic effects of exosomes from different cell sources and doses in rat knee osteoarthritis models using network meta-analysis, and to identify potential optimal strategies for preclinical optimization and clinical hypothesis generation.</p><p><strong>Methods: </strong>A systematic search of PubMed, Web of Science, Embase, and Scopus identified 27 eligible randomized controlled trials (456 rats). Traditional random-effects meta-analysis and frequentist network meta-analysis were conducted. Treatments were ranked using SUCRA values.</p><p><strong>Results: </strong>A total of 27 studies were included, comprising 456 rats. Traditional meta-analysis revealed that exosome therapy significantly reduced joint cartilage histopathological damage (reduced OARSI score: SMD = -3.78, 95% CI: -4.76, -2.80), promoted type II collagen synthesis (SMD = 3.41, 95% CI: 1.87, 4.95), and suppressed the expression of the inflammatory cytokine IL-1β (SMD = -3.26, 95% CI: -4.08, -2.44). Network meta-analysis further indicated that under high-dose conditions (≥100 μg), exosomes derived from human amniotic fluid stem cells (hAFSCs-Exo) and human umbilical cord mesenchymal stem cells (hUCMSCs-Exo) ranked highest in relative efficacy for improving the OARSI score. hUCMSCs-Exo also demonstrated the most potent anti-inflammatory effect by reducing IL-1β. Overall, exosome therapy exhibited a dose-related trend in efficacy, with high-dose transplantation showing higher probabilistic SUCRA rankings across most outcome measures. However, assessment of publication bias revealed marked asymmetry; after trim-and-fill correction, the effect size for type II collagen expression decreased from SMD = 3.41 to 1.26, suggesting that the magnitude of the treatment effect may have been overestimated. This overestimation reduces the certainty of the observed treatment effects. Despite the presence of publication bias and methodological limitations, the main conclusions remained statistically robust after trim-and-fill correction.</p><p><strong>Conclusion: </strong>Current evidence from rat models suggests that exosome therapy may substantially ameliorate the pathological progression of KOA, with exosomes derived from early developmental tissues, particularly hAFSCs-Exo and hUCMSCs-Exo, showing favorable chondroprotective and anti-inflammatory effects in the probabilistic ranking when administered at high doses. Nevertheless, the findings from publication bias and trim-and-fill analyses indicate that the existing effect sizes are likely overestimated. These results require confirmation in larger-scale, methodologically more rigorous preclinical studies.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13485348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148798116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced mechanical shear is associated with early cortical differentiation and GDNF-GFRA1/RET signalling in human brain organoids. 在人脑类器官中,机械剪切减少与早期皮层分化和GDNF-GFRA1/RET信号传导有关。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag070
Zizhen Zhao, Jingran Du, Shan Zhang, Haowen Shi, Hui Chen, Hong Cheng, Lihua Zhou, Chenju Yi, Jiachuan Wang
{"title":"Reduced mechanical shear is associated with early cortical differentiation and GDNF-GFRA1/RET signalling in human brain organoids.","authors":"Zizhen Zhao, Jingran Du, Shan Zhang, Haowen Shi, Hui Chen, Hong Cheng, Lihua Zhou, Chenju Yi, Jiachuan Wang","doi":"10.1093/stcltm/szag070","DOIUrl":"10.1093/stcltm/szag070","url":null,"abstract":"<p><p>Early cortical differentiation in human brain organoids is a critical step of corticogenesis, but remains poorly coordinated under conventional culture conditions. In a standard orbital shaker system, mechanical shear and variability in extracellular matrix support, can disrupt neuroepithelial organisation, leading to inconsistent early cortical differentiation. Here, we investigated how ClinoStar-associated low-shear culture conditions affect early corticogenic marker expression in brain organoids and examined GFRA1/RET-related signaling as a candidate pathway associated with these culture-related effects. Using a low-shear ClinoStar bioreactor, we observed improved neuroepithelial-like expansion, enhanced tissue organisation, and promoted early cortical differentiation during the neuroepithelial expansion stage. Compared with conventional conditions, low-mechanical shear in ClinoStar was associated with increased proliferation capacity and supported the number of TBR2+ intermediate progenitors and TBR1+ early cortical neurons. Transcriptomic analysis revealed enrichment of neuronal differentiation and neuroactive ligand-receptor interaction pathways, with increased upregulation of GDNF signalling components under reduced mechanical shear. Functional experiments showed that GDNF supplementation increased TBR2+ intermediate progenitor-associated and TBR1+ early neuronal marker-related populations in brain organoids, suggesting a positive effect on early corticogenic marker expression. Consistent with this, GFRA1/RET levels were elevated in organoids in the ClinoStar culture with low-mechanical shear stress, and manipulation of GFRA1 affected early cortical differentiation outcomes. These findings suggest that ClinoStar low-shear culture promoted early corticogenic marker expression, potentially associated with GDNF-GFRA1/RET signalling. Collectively, this study provides a refined culture framework for improving the reproducibility and structural organisation of human brain organoid models of early cortical differentiation.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13553076/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148913670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why retracted articles can have an influential afterlife-and what to do about it. 为什么撤回的文章会对后世产生影响,该怎么办?
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag080
Jeremy Snyder, Leigh Turner
{"title":"Why retracted articles can have an influential afterlife-and what to do about it.","authors":"Jeremy Snyder, Leigh Turner","doi":"10.1093/stcltm/szag080","DOIUrl":"10.1093/stcltm/szag080","url":null,"abstract":"<p><p>Retractions of published journal articles are an increasingly common means by which the research community ensures the quality and integrity of publications and addresses research misconduct missed during pre-publication peer review. Retractions are intended to notify the public of issues that undermine the integrity of these publications so that readers will not rely on their findings and conclusions. Continued citation and other uses of these publications without acknowledging their retracted status are therefore problematic and suggest shortcomings in retraction processes. In this commentary, we use the examples of retracted articles published in this journal to outline ways in which retracted articles can maintain an influential afterlife in the academic literature, online materials from non-profit organizations and private businesses, and responses from generative artificial intelligence. Given that this ongoing influence compounds the harms of these publications, we recommend changes in how publishers manage article retractions. These changes include ensuring that article retraction notices are maintained when journal publishing agreements change, increasing the visibility of retractions, and notifying scholars and members of the public when an article they reference is retracted. While these changes will make article retractions more effective, there is a continued need to limit the publication of studies that violate the requirements of research integrity.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13549933/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MSCs derived from ADSC-reprogrammed iPSCs exhibit enhanced therapeutic potential for treating skin fibrosis. 来自adsc重编程iPSCs的MSCs在治疗皮肤纤维化方面表现出增强的治疗潜力。
IF 5.9 2区 医学
Stem Cells Translational Medicine Pub Date : 2026-08-18 DOI: 10.1093/stcltm/szag063
Liquan Wang, Mingfei Lu, Meili Zhang, Lin Kang, Fengzhou Du, Nanze Yu, Jiuzuo Huang, Yue Huang, Xiao Long
{"title":"MSCs derived from ADSC-reprogrammed iPSCs exhibit enhanced therapeutic potential for treating skin fibrosis.","authors":"Liquan Wang, Mingfei Lu, Meili Zhang, Lin Kang, Fengzhou Du, Nanze Yu, Jiuzuo Huang, Yue Huang, Xiao Long","doi":"10.1093/stcltm/szag063","DOIUrl":"10.1093/stcltm/szag063","url":null,"abstract":"<p><strong>Background: </strong>Localized scleroderma (LoS) is a fibrotic skin disorder characterized by excessive collagen deposition, leading to functional and cosmetic impairments. Mesenchymal stromal cells (MSCs) offer therapeutic potential through immunomodulation and tissue repair, but their clinical use is limited by donor variability and replicative senescence. Induced pluripotent stem cell (iPSC)-derived MSCs (iMSCs) present a promising alternative owing to their scalable production and rejuvenated phenotype.</p><p><strong>Methods: </strong>We generated adipose-derived iMSCs (AD-iMSCs) from reprogrammed adipose-derived stem cells (ADSCs) and compared their therapeutic efficacy to primary ADSCs in vitro and in vivo. Functional assays including transcriptomic profiling, conditioned medium (CM) effects on fibrosis markers (α-SMA, TGF-β/Smad), and angiogenesis were conducted. A bleomycin-induced murine LoS model was employed to assess AD-iMSC engraftment, collagen deposition, and microvascularization.</p><p><strong>Results: </strong>AD-iMSCs exhibited rejuvenated-like phenotype, with reduced senescence markers and enhanced proliferative capacity. AD-iMSC-derived conditioned medium (AD-iMSCs-CM) outperformed ADSC-derived conditioned medium (ADSC-CM) in promoting angiogenesis in vitro. In vivo, AD-iMSCs demonstrated superior persistence and therapeutic efficacy, notably decreasing dermal thickness and collagen density while promoting vascularization. Mechanistically, AD-iMSCs more effectively suppressed the TGF-β/Smad2/3 signaling and extracellular matrix (ECM) remodeling pathways compared to ADSCs.</p><p><strong>Conclusion: </strong>In conclusion, our findings provide a robust preliminary proof-of-concept demonstrating that iPSC-mediated reprogramming yields iMSCs with rejuvenated-like phenotype and a potent anti-fibrotic secretome. These data offer a valuable molecular and functional rationale for the prospective development of iMSC-based platforms to circumvent the expansion limitations and donor variability inherent to primary MSC therapies for fibrotic skin disorders.</p>","PeriodicalId":21986,"journal":{"name":"Stem Cells Translational Medicine","volume":"15 9","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13533559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148875735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书